Literature DB >> 11013266

Inhibition of Trypanosoma brucei gene expression by RNA interference using an integratable vector with opposing T7 promoters.

Z Wang1, J C Morris, M E Drew, P T Englund.   

Abstract

RNA interference is a powerful method for inhibition of gene expression in Trypanosoma brucei (Ngo, H., Tschudi, C., Gull, K., and Ullu, E. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 14687-14692). Here we describe a vector (pZJM) for in vivo tetracycline-inducible synthesis of double-stranded RNA (dsRNA) in stably transformed cells. The dsRNA is synthesized from opposing T7 promoters. We tested the vector with genes involved in processes such as kinetoplast DNA replication, mitochondrial mRNA synthesis, glycosyl phosphatidylinositol biosynthesis, glycosome biogenesis, and polyamine biosynthesis. In most cases the induction of dsRNA caused specific and dramatic loss of the appropriate mRNA, and in many cases there was growth inhibition or cell death. One striking phenotype was the loss of kinetoplast DNA after interference with expression of a topoisomerase II. The gene being analyzed by this procedure need not even be fully sequenced. In fact, many of the genes we tested were derived from partial sequences in the T. brucei genome data base that were identified by homology with known proteins. It takes as little as 3 weeks from identification of a gene sequence in the data base to the appearance of a phenotype.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11013266     DOI: 10.1074/jbc.M008405200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  260 in total

1.  RNA interference in Trypanosoma brucei: cloning of small interfering RNAs provides evidence for retroposon-derived 24-26-nucleotide RNAs.

Authors:  A Djikeng; H Shi; C Tschudi; E Ullu
Journal:  RNA       Date:  2001-11       Impact factor: 4.942

2.  Eukaryotic-type elongator tRNAMet of Trypanosoma brucei becomes formylated after import into mitochondria.

Authors:  Timothy H P Tan; Natacha Bochud-Allemann; Elke K Horn; Andre Schneider
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-15       Impact factor: 11.205

3.  RNA interference of a trypanosome topoisomerase II causes progressive loss of mitochondrial DNA.

Authors:  Z Wang; P T Englund
Journal:  EMBO J       Date:  2001-09-03       Impact factor: 11.598

4.  Roles of triosephosphate isomerase and aerobic metabolism in Trypanosoma brucei.

Authors:  S Helfert; A M Estévez; B Bakker; P Michels; C Clayton
Journal:  Biochem J       Date:  2001-07-01       Impact factor: 3.857

5.  Assembly and function of the RNA editing complex in Trypanosoma brucei requires band III protein.

Authors:  Catherine E Huang; Sean F O'Hearn; Barbara Sollner-Webb
Journal:  Mol Cell Biol       Date:  2002-05       Impact factor: 4.272

6.  Mitochondrial development during life cycle differentiation of African trypanosomes: evidence for a kinetoplast-dependent differentiation control point.

Authors:  Mark W Timms; Frederick J van Deursen; Edward F Hendriks; Keith R Matthews
Journal:  Mol Biol Cell       Date:  2002-10       Impact factor: 4.138

7.  Novel and essential subunits in the 300-kilodalton nuclear cap binding complex of Trypanosoma brucei.

Authors:  Hongjie Li; Christian Tschudi
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

8.  Two trypanosome-specific proteins are essential factors for 5S rRNA abundance and ribosomal assembly in Trypanosoma brucei.

Authors:  Kristina M Hellman; Martin Ciganda; Silvia V Brown; Jinlei Li; William Ruyechan; Noreen Williams
Journal:  Eukaryot Cell       Date:  2007-08-22

9.  Clathrin-mediated endocytosis is essential in Trypanosoma brucei.

Authors:  Clare L Allen; David Goulding; Mark C Field
Journal:  EMBO J       Date:  2003-10-01       Impact factor: 11.598

10.  Distinct roles of a mitogen-activated protein kinase in cytokinesis between different life cycle forms of Trypanosoma brucei.

Authors:  Ying Wei; Ziyin Li
Journal:  Eukaryot Cell       Date:  2013-11-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.